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Abstracts
Background: The aim of this study was to systematically evaluate the diagnostic performance of nCD64 for
neonatal sepsis.
Methods: Computer retrieval was conducted for the databases of PubMed, Embase, and Springer databases up to
March 18, 2015 to select the relevant studies on nCD64 and neonatal sepsis. Sensitivity, specificity, positive
likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and 95 % confidence intervals (CI)
for diagnostic efficiency of nCD64 were pooled. In addition, the summary receiver operating characteristic (SROC)
curve was also conducted based on the sensitivity and specificity.
Results: Seventeen studies including 3478 participants were included in this meta-analysis. The overall pooled
sensitivity, specificity, PLR, NLR and DOR were 0.77 (95 % CI: 0.74–0.79), 0.74 (95 % CI: 0.72–0.75), 3.58 (95 %
CI: 2.85–4.49), 0.29 (95 % CI: 0.22–0.37) and 15.18 (95 % CI: 9.75–23.62), respectively. In addition, the area
under the SROC curve (AUC) was 0.8666, and no threshold effect was found based on the Spearman
correlation analysis (P = 0.616). Besides, subgroup analysis showed higher sensitivity, specificity and AUC in
term infants and proven infection group than those in preterm infants and clinical infection group,
respectively.
Conclusions: The n CD64 expression alone is not a satisfactory marker for diagnosing neonatal sepsis with
relatively low sensitivity, specificity, PLR and NLR, in spite of relatively high SROC area. Therefore, the n CD64
expression used in diagnosis of neonatal sepsis should be treated with caution.
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Background
Neonatal sepsis is one of the important causes of
neonatal mortality. Despite the improvement in man-
agement of newborn infant, the mortality caused by
neonatal sepsis remains high (~10 %) [1]. It is diffi-
cult to diagnose neonatal sepsis during early stage
because of the nonspecific and variable clinical
symptoms. Blood culture is the current golden
standard for confirming the neonatal sepsis. How-
ever, the results of blood culture could be available
within 24–48 h of culture. Usually, the antibiotics
would be discontinued if the blood culture results
were negative by 48 h [2, 3]. Moreover, the results
are negative in cases with meningitis and pneumonia
[4]. There is a high false-negative rate of blood cul-
ture [5]. Therefore, considering the limitations of
blood culture in neonatal sepsis diagnosis, new bio-
markers for early and rapid diagnosis of neonatal
sepsis should be developed.
Recently, neutrophil CD64 (nCD64) has been re-
ported as a diagnostic marker of neonatal sepsis, be-
cause nCD64 expression is stable for 24 h and can be
detected rapidly by flow cytometer with minimal
blood volumes [6]. However, the diagnostic accuracy
of nCD64 remains unclear due to the large range of
sensitivity (0.26–0.95) and specificity (0.62–0.97) in
different individual studies [7–9]. Although a meta-
analysis has been conducted by Jia et al. in 2013 [10],
they combined the results of median monocyte/
nCD64 ratio with nCD64 expression, which might be
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a source of heterogeneity. In addition, recently new
individual studies [11, 12] on this topic have reported
conflicting results with Jia et al. [10]. Thus, there is a
need to update the exploration.
In this study, we performed an updated meta-analysis
to systematically evaluate the diagnostic performance of
nCD64 for neonatal sepsis.
Methods
Because the data of this manuscript come from the pub-
lic databases and previous studies, it is not applicable to
receive the ethics committee approval or follow the Dec-
laration of Helsinki, and there is no need to get in-
formed consent of patients.
Search strategy
We systematically searched the PubMed, Embase and
Springer databases up to 18 March, 2015 with the
following search terms: (septicemia or septicaemia or
sepsis or infection) and (neutrophil CD64 or nCD64).
We also manually searched the printed articles, and
the references of the reviews and the included
studies.
Inclusion and exclusion criteria
The studies were included if they met the following cri-
teria: 1) exploring the diagnostic value of the nCD64 for
sepsis; 2) reporting the babies within 28 days of birth; 3)
providing the golden standard of blood culture; 4) giving
the number of true positive (TP), false positive (FP), true
negative (TN) and false negative (FN).
The following studies were excluded: 1) the studies
were written in a language other than English; 2) re-
views, letters and reports.
Data extraction and quality assessment
Two investigators independently extracted the following
data using a standard form: name of the first author,
publication year, study region, diagnostic golden stand-
ard, detection method and cut-off value of nCD64, TP,
FP, TN and FN. They exchanged the form after filling
out the data extraction. Discrepancies were solved by
discussing with each other.
The quality of the included studies was assessed by
using a 14-item Quality Assessment of Diagnostic Ac-
curacy Studies (QUADAS) list [13]. Each item was de-
scriptively assessed with yes, unclear or no and scored
by 1, 0, -1, respectively [14]. Total scores were produced
by plus the scores of each item.
Statistical analysis
The statistical analysis was performed using Meta-
disc software (version 1.4) [15]. The sensitivity, spe-
cificity, positive likelihood ratio (PLR), negative like-
lihood ratio (NLR), diagnostic odds ratio (DOR) and
95 % confidence interval (CI) for diagnostic effi-
ciency of nCD64 were pooled. The heterogeneity
among studies was evaluated by Cochran Q test and
I2 statistic [16]. P < 0.05 or I2 > 50 % was considered
statistically significant and a random effects model
was used for pooling the data; otherwise, a fixed ef-
fect model was utilized. The summary receiver oper-
ating characteristic (SROC) curve was also
conducted based on the sensitivity and specificity.
The area under the curve (AUC) close to 1 indicated
a good diagnostic performance of nCD64 [17].
Threshold effect was assessed using Spearman cor-
relation analysis, and P < 0.05 indicated a significant
threshold effect [18]. Subgroup analyses based on
the diagnosis standard for infection (clinical or
proven infection), type of sepsis (early-onset or late-
Fig. 1 The process of the study selection
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Table 1 Characteristics of included studies
ID Author Year Area n Episodes of sepsis Infected/noninfected Diagnosis standard Type of sepsis Infants nCD64 analysis Analysis cut-off TP FP FN TN
1 Bhandari 2008 [7] USA 163 293 128/165 Clinical or proven b Preterm FCM 2.30* 90 63 38 102
2 Dilli 2010 [21] Turkey 109 109 35/74 Clinical or proven c Preterm + term FCM 4.39* 31 11 4 63
3 Genel 2012 [22] Turkey 119 119 49/70 Clinical or proven c Preterm + term FCM 3.05 MFI 40 16 9 54
4 Groselj-Grenc 2009 [23] Slovenia 46 46 17/29 Clinical or proven c Preterm + term FCM 1.86* 13 6 4 23
5 Lam 2011 [24] China 310 310 136/174 Clinical or proven a Preterm + term FCM 6010 $ 107 37 29 137
6 Motta 2014 [25] Italy 129 129 48/81 Clinical or proven a Preterm FCM 2.4* 31 12 17 69
7 Ng 2004 [26] China 359 359 115/244 Clinical or proven a Term FCM 5500 $ 93 46 22 198
8 Ng 2006 [27] China 298 298 93/205 Clinical or proven a Term FCM 6136 $ 73 20 20 185
9 Zeitoun 2010 [30] USA 98 98 49/49 Clinical or proven c Preterm + term FCM 2.6* 45 14 4 35
10 Du 2014 [11] China 158 158 88/70 Clinical a Preterm FCM 1010 $ 72 21 16 49
11 Elawady 2014 [12] Egypt 50 50 25/25 Clinical b Preterm + term FCM 46.0 24 0 1 24
12 Layseca-Espinosa 2002 [8] Mexico 29 29 14/15 Clinical c Preterm + term FCM # 3 0 11 15
13 Streimish(a) 2014 [29] USA 684 1156 207/416 Clinical a Preterm FCM 1.63 139 137 68 279
14 Streimish(b) 2014 [29] USA 204/329 Clinical b Preterm FCM 2.19 159 135 45 194
15 Choo 2012 [20] Korea 23 23 11/12 Proven c Preterm + term FCM 3.0* 10 2 1 10
16 Elawady 2014 [12] Egypt 50 50 25/25 Proven b Preterm + term FCM 45.8 24 0 1 25
17 Layseca-Espinosa 2002 [8] Mexico 34 34 17/17 Proven c Preterm + term FCM # 5 1 12 16
18 Ng 2002 [9] China 110 147 37/110 Proven b Preterm FCM 4000 $ 35 13 2 97
19 Soni 2013 [28] India 60 60 24/36 Proven c Preterm + term FCM 2.765* 22 12 2 24
20 Streimish(a) 2012 [19] USA 649 997 3/577 Proven a Preterm FCM 2.38 3 185 0 392
21 Streimish(b) 2012 [19] USA 47/370 Proven b Preterm FCM 3.62 35 85 12 285
a, early-onset; b, late-onset; c, early & late-onset; *, CD64 index; FCM, flow cytometric technology; MFI: mean fluorescence intensity; Clinical infection defined as infection suspected on a clinical basis; proven infection










onset), infants (preterm or term) were conducted.
Clinical infection means infection suspected on a
clinical basis whereas proven infection means culture
proven infections with an identified microorganism.
In addition, a meta-regression analysis was con-




The process of the study selection is shown in Fig. 1.
We identified 1,245 studies by the initial search
(Embase: 533, PubMed: 225, Springer: 487). Firstly,
211 duplicate studies were removed. Then, by review-
ing titles and abstracts, 1,013 studies that did not
meet the inclusion criteria were ruled out. In
addition, 2 reviews and 2 studies including children
population were precluded by reading full-texts. Fi-
nally, 17 studies [7–9, 11, 12, 19–30] were included
in this meta-analysis.
Characteristics of the included studies
The characteristics of the 17 included studies were
listed in Table 1. There were totally 3478 participants
involved in this meta-analysis. Nine of the included
studies distributed in Asia, 2 in Europe, 5 in America
and 1 in Africa. The diagnostic golden standard in-
cluded clinical test, hematological and biochemical la-
boratory investigations, and microbiological test-blood
culture. The expression of nCD64 was assessed by
flow cytometry. As shown in Table 2, the quality of
the included studies was relatively high, because most
of the total scores ≥ 10.
Pooled analysis
As shown in Fig. 2, the pooled sensitivity and specifi-
city were 0.77 (95 % CI: 0.74–0.79) and 0.74 (95 %
CI: 0.72–0.75), respectively. The pooled PLR and NLR
were 3.58 (95 % CI: 2.85–4.49) and 0.29 (95 % CI:
0.22–0.37), respectively (Fig. 3). In addition, the
pooled DOR was 15.18 (95 % CI: 9.75–23.62, Fig. 4).
For all above effect sizes, significant heterogeneities
were observed (P < 0.001, I2 > 50 %). From the SROC
in Fig. 4, AUC was 0.8666, and no threshold effect
was found based on the Spearman correlation analysis
(P = 0.616).
Subgroup analysis
The results of subgroup analyses are summarized in
Table 3. Higher sensitivity, specificity, PLR, DOR,
AUC and Q*, and lower NLR were observed in the
proven infection group (0.82, 0.74, 4.14, 30.58, 0.9136
and 0.8461, and 0.17) compared with those in clinical
infection group (0.74, 0.66, 2.19, 6.98, 0.8245 and
0.7576, and 0.39). Slightly higher specificity, PLR and
NLR, while lower sensitivity, DOR, AUC, and Q were
found in the early-onset sepsis, compared with those
in the late-onset sepsis. There were higher sensitivity,
Table 2 Quality assessment of the included articles
Studies QUADAS list item
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Bhandari, 2008 [7] + 0 + + + + + + 0 0 + + 0 +
Choo, 2012 [20] + - + + + + + + 0 0 + + - +
Dilli, 2010 [21] + + + + + + + + + 0 + 0 + +
Du, 2014 [11] + + + + + + + + - + + + 0 +
Elawady, 2014 [12] + + + + + + + + + 0 + 0 + +
Genel, 2012 [22] + + + + + + + + 0 0 + 0 + +
Groselj-Grenc, 2009 [23] + 0 + + + + + + + 0 + + + +
Lam, 2011 [24] + 0 + + + + + + + + + + 0 +
Layseca-Espinosa, 2002 [8] + 0 + + + + + - + 0 + 0 0 +
Motta, 2014 [25] + - + + + + + + + 0 + 0 + +
Ng, 2002 [9] - + + + + + + + 0 0 + 0 + +
Ng, 2004 [26] + + + + + + + + + 0 + + + +
Ng, 2006 [27] + + + + + + + + + 0 + + + +
Soni, 2013 [28] + 0 + + + + + + + 0 + + + +
Streimish, 2012 [19] + 0 + + + + + + 0 0 + + 0 +
Streimish, 2014 [29] + 0 + + + + + + 0 0 + + 0 +
Zeitoun, 2010 [30] + + + + + + + + 0 0 + 0 0 +
Abbreviation: QUADAS Quality Assessment of Diagnostic Accuracy Studies. +: YES; -: NO; 0: not clear
Shi et al. Italian Journal of Pediatrics  (2016) 42:57 Page 4 of 9
specificity, PLR and DOR, and lower NLR in term in-
fants (0.80, 0.85, 5.75 and 24.07, and 0.24) compared
with those in preterm infants (0.74, 0.69, 2.76 and
7.83, and 0.37).
Meta-regression analysis
Meta-regression analysis (Table 4) showed that the “in-
fants” was the cause of heterogeneity (P = 0.0147) and
other variances were not the sources of heterogeneity
(P > 0.05).
Discussion
nCD64 can be detected rapidly by flow cytometer
with minimal blood volumes [6] and is reported
widely to be used in the diagnosis of neonatal sepsis.
This meta-analysis showed that the diagnostic per-
formance of nCD64 for neonatal sepsis was not
good, because the pooled sensitivity and specificity
are not high enough. The PLR and NLR were also
not satisfactory. Although the AUC is relatively high,
the application of nCD64 for diagnosing neonatal
sepsis needs to be cautious.
The pooled sensitivity and specificity of nCD64
were 77 % and 74 %, respectively, which are lower
than those of serum procalcitonin (PCT) (81 % and
79 %), although AUC was similar (0.87) [31]. Indica-
tors of nCD64 diagnostic value were lower than CRP
(sensitivity 80.8 %, specificity 100 %, AUC 0.90), TNF-
α (sensitivity 100 %, specificity 96.6 %, AUC 1) and
IL-6 (sensitivity 96.2 %, specificity 89.7 %, AUC 0.97)
according data of study of Kocabas E et al. [32].
Compared with the novel marker such as presepsin
[33–37], nCD64 also showed a lower diagnostic effi-
ciency. Thus, our results indicate that the nCD64
Fig. 2 The forest plots of sensitivity (a) and specificity (b) of neutrophil CD64 for neonatal sepsis diagnosis
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should not be used as a diagnostic marker alone for
neonatal sepsis. It can be combined with other diag-
nostic methods like serum PCT [38] and hematologic
scoring system (sensitivity 93 %; specificity 82 %) [39]
to improve the diagnostic accuracy. The hematologic
scoring system assigns one score for each of seven in-
dexes (abnormal total leukocyte count, abnormal total
neutrophil (PMN) count, elevated immature PMN
count, elevated immature to total PMN ratio, Imma-
ture to mature PMN ratio ≥ 0.3, platelet count ≤
150,000/mm3, and pronounced degenerative changes
in PMNs) with higher scores indicating greater likeli-
hood [39].
The results of the present study are similar with the
previous meta-analysis of 12 studies (sensitivity, 78 %;
specificity, 81 %; DOR, 21.27; PLR, 4.53; NLR, 0.23;
AUC, 0.89.) [10]. Although nCD64 showed relatively
high sensitivity and specificity in some included studies
with cutoff of 2.3 % [7], 4000 phycoerythrinmolecules
bound per cell [9], and 2.6 % [30], respectively, the small
sample size and different cut-off may exaggerate the fac-
ticity of the results.
nCD64 expressed normally in non-infected neutro-
phils, but it could be up-regulated by stimulation of
bacterial invasion [40]. It has been shown that the
expression of nCD64 was not affected by transient
tachypnea of the newborn (TTN), respiratory distress
syndrome (RDS) and other non-infective perinatal
events [21]. nCD64 expression in adults is different
from newborn neonates. In adults, the expression of
nCD64 may be higher in gram-negative sepsis than
in gram-positive sepsis [41]. However, this difference
has not been confirmed in neonates [21]. Neonates
may have less expressed neutrophil to gram-negative
bacteria infection. Furthermore, the expression of
nCD64 may also been increased in leucocytes in
Fig. 3 The forest plots of positive likelihood ratio (a) and negative likelihood ratio (b) of neutrophil CD64 for neonatal sepsis diagnosis
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patients with streptococcal infection [42]. All these
lead to the lower power of nCD64 in diagnosis of
neonatal sepsis.
Identification of the cut-off value of a diagnostic
marker is difficult. If the cut-off value is high, the
false positive rate may be overestimated. On the con-
trary, the low cut-off value may lead to overesti-
mation of the false negative rate. Therefore, an
appropriate cut-off value is necessary for improving
the diagnostic accuracy of nCD64. In this study, cut-
off values of nCD64 in included studies are different.
Various cut-offs used in different studies might result
in a threshold effect which is a cause of heterogeneity
[43]. In the present study, no threshold effect was
found based on the Spearman correlation analysis (P
= 0.616), indicating that the threshold effect is not a
cause of the high heterogeneity. The heterogeneity
may be explained by the characteristics of the in-
cluded patients. Some included neonates have other
infections, which can also regulate the expression of
nCD64. In addition, combination of studies with
proven and clinical sepsis, data from preterm with
Fig. 4 The diagnostic odds ratio (DOR) (a) and the summary receiver operating characteristic (SROC) (b) curve
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term infants, and studies with early- and late-onset
sepsis may also introduce heterogeneity. Therefore,
we conducted the subgroup analysis based on these
factors. The results revealed that higher sensitivity,
specificity, PLR, AUC and Q* and lower NLR in the
proven infection group than those in clinical infection
group. There was higher sensitivity, specificity, PLR,
DOR and lower NLR in term infants compared with
those in preterm infants. No consistent differences in
sensitivity, specificity, PLR, NLR, AUC and Q* were
found between early-onset and late-onset sepsis.
These results indicated that this method is more suit-
able for term infants than preterm infants, based on
proven infection than other clinically suspected
infection.
Heterogeneity is a common limitation of meta-
analysis, especially in diagnostic meta-analysis. In the
present study, meta-regression revealed that types of
infants was one cause of the heterogeneity. Although
subgroup analysis was performed based on the diag-
nostic method, types of sepsis (early-onset or late-
onset), and preterm or term, the influences of other
factors like the cutoff values were not assessed due to
the lack of included studies and unavailable data. This
reminds the clinical researchers providing more de-
tails of the patients in further studies, including the
stage and types of neonatal sepsis. In addition, the
appropriate and uniform cut-off value of nCD64
should be confirmed in further clinical studies.
Conclusions
In conclusion, the n CD64 expression alone is not a sat-
isfactory marker for diagnosing neonatal sepsis with
relatively low sensitivity, specificity, PLR and NLR, in
spite of relatively high SROC area. Therefore, the n
CD64 expression used in diagnosis of neonatal sepsis
should be treated with caution.
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